United Kingdom
In Britain you can pay to skip the queue. That changes the question.
Most companies selling treatment abroad open with the waiting list. The more useful place to start is with what you can already do at home.
If you are on an NHS waiting list and weighing your options, start here. Unlike patients in some other countries, you are allowed to buy private treatment in the UK, and for a straightforward operation that is very often the right answer once you compare UK medical cost against the whole cost of travelling. For a routine procedure the saving often shrinks, and sometimes disappears, once you count flights, a companion, accommodation and time away from work.
Roughly £12,000 to £18,000
is the typical private package price for a hip or knee replacement in the UK, reported through PHIN, the body set up under the Competition and Markets Authority order requiring UK private hospitals to publish comparable pricing
Private Healthcare Information Network (PHIN), via secondary reporting Checked 2026-09-02.
PHIN's own site blocks automated access, the same way some professional registries do, so this is compiled from secondary coverage of PHIN's published figures rather than read directly from PHIN. A real, individual quote from a specific UK hospital is the number that actually matters for a decision, not this range.
Where the arithmetic changes is at the complex end: revision surgery, a second or third operation on the same joint, or a case several British surgeons have already declined. That is the narrow band where travelling is worth considering, and it is the only band we will encourage you into.
Medically reviewed
Reviewed by Dr Gunjan Patel, MBBS, registered with the Gujarat Medical Council (G-65059). Reviewed for accuracy only. This page is general information, not advice about your own case, and Dr Gunjan Patel does not diagnose, prescribe or treat.
The wait, in numbers
The scale is real, and it is worth stating precisely.
These are NHS England's own published figures, not an industry estimate.
7.37 million
pathways were waiting to start consultant-led treatment in England at the end of August 2026, including NHS England estimates for four trusts that submitted no data. Some patients are on more than one pathway, and NHS England estimates about 6.2 million unique patients
NHS England, referral to treatment (RTT) statistical press notice and overview time series, August 2026, published 8 October 2026 Checked 2026-10-08.
England only. The notice rounds the total to 7.4 million; 7.37 million is from the overview workbook that includes the estimates for missing trusts. The notice puts the list 0.5 percent (33,512 pathways) lower than at the end of August 2025. The workbook has it at 7.11 million at the end of March 2026, so it has grown over those five months.
2.56 million
pathways in England had been waiting more than 18 weeks to start treatment at the end of August 2026, and 113,339 had been waiting more than 52 weeks
NHS England, referral to treatment (RTT) statistical press notice and overview time series, August 2026, published 8 October 2026 Checked 2026-10-08.
Pathways, not patients: some patients are on more than one pathway. Both counts include NHS England estimates for four trusts that submitted no data. The 2.56 million is from the overview workbook (2.49 million without the estimates); the 113,339 is printed in the notice (109,936 without the estimates, from the workbook).
12.2 weeks
was the median time already waited by pathways still waiting to start treatment in England at the end of August 2026; the 92nd percentile was 38.8 weeks, and the median in February 2020 was 7.5 weeks
NHS England, referral to treatment (RTT) statistical press notice and overview time series, August 2026, published 8 October 2026 Checked 2026-10-08.
This is the time waited so far by people still on the list. It does not say when anyone will be seen. NHS England calculates it from aggregate data, so it is an estimate, and it excludes estimates for trusts that did not submit data. The February 2020 figure comes from the overview time series workbook on NHS England’s RTT statistics page, not from the notice. Since February 2024 community service pathways should no longer be reported in RTT data, so the comparison with 2020 is not exactly like for like.
The direction of travel matters as much as the number. In the twelve months to August 2026 the number of pathways on the England list fell by 0.5 percent and the share waiting up to 18 weeks rose by 4.2 percentage points, but since March 2026 that share has stayed at about 65 percent while the list itself has grown from 7.11 million to 7.37 million pathways.
65.2 percent
of consultant-led pathways in England still waiting to start treatment at the end of August 2026 had been waiting up to 18 weeks, against the 92 percent standard; the figure was 65.3 percent at the end of March 2026
NHS England, referral to treatment (RTT) statistical press notice and overview time series, August 2026, published 8 October 2026 Checked 2026-10-08.
England only. A snapshot of the waiting list, not the share of patients treated within 18 weeks. Includes NHS England estimates for four trusts that submitted no data. The notice puts the share 4.2 percentage points higher than at the end of August 2025, and the monthly figure stayed between 65.0 and 65.8 percent from March to August 2026.
What the numbers do not tell you
The median describes people already on the list: at the end of August 2026, half of the pathways still waiting in England had waited 12.2 weeks or less so far. It does not tell you when you will be seen. If you already have a date that is soon enough for your condition and your consultant is comfortable with it, the rest of this page is probably not for you yet.
The group this page is written for is much smaller and much more specific: people whose own wait is measured in seasons rather than weeks, and whose procedure is complicated enough that price at home has become the obstacle. If you are unsure how much a long wait matters for your own condition, our guide to whether waiting for surgery harms you sets out what published studies found.
The argument against us
A private hospital in Britain is an hour away. India is nine.
This is the strongest case against travelling, and any company that does not put it to you is not being straight with you.
Stay in Britain when
- Your procedure is a first time, uncomplicated one
- A UK private quote is within reach of what you can fund
- You have a condition that makes a long flight unwise
- You would be travelling alone with nobody to help you afterwards
- Your own consultant is confident and you simply want it sooner
Recovering ninety minutes from home, with your own GP down the road, has a value that does not appear on any price comparison.
India is worth pricing when
- The operation is a revision, or a repair of surgery that did not go to plan the first time
- UK private quotes for your specific case have come back beyond your means
- You have been told the expertise you need sits with a small number of surgeons and none of them can see you soon
- The gap between a British private price and the whole Indian journey is large enough to still be large after every extra cost
You would not be alone
Many British residents already travel abroad for treatment.
523,000
is the Office for National Statistics estimate of visits abroad for medical treatment made by residents of Great Britain in 2024. It counts completed visits, not people, so someone who travelled twice counts twice
ONS publishes these as official statistics in development, from the International Passenger Survey under a new data collection design. The figure is rounded to the nearest 1,000, ONS gives no confidence intervals, so the uncertainty is unknown, and Northern Ireland is not included. India accounts for 22,000 of these visits in the same table.
1,927,150
people of Indian origin live in the United Kingdom
UK Census 2021/22 Checked 2026-08-19.
656,272
people of Indian ethnicity live in London, the largest minority ethnic group in the capital, concentrated in Harrow, Brent, Hounslow, Hillingdon and Ealing
ONS Census 2021, Greater London Authority Checked 2026-09-07.
If you are weighing medical treatment in India from London specifically, that is not a small detail. It means the direct flights, the language, and often a relative who has already made the same journey are already closer to you than they are to most of the country.
For a great many British families, India is not an unfamiliar country reached through a brochure. It is where relatives live, where someone can meet you at the airport, and where the language of the consultation is one you already share.
Where that is true, it removes a real part of the risk, because you have people around you. Where it is not true, we plan for it rather than leaving you to discover it.
Six things to settle before you commit
- A written UK private quote for the same operation, so the comparison is real rather than notional
- Whether your GP will take back your follow up, agreed in advance and in writing
- Your travel insurance position, since most policies exclude planned treatment abroad
- A medical visa, and how long yours will take from your nearest centre
- Who travels with you, and what that person costs in flights, time off and accommodation
- What happens, and who pays, if you need to stay longer than planned
Every cost line, including the ones that go wrong
What the NHS and FCDO say about insurance for planned treatment abroad
Weight loss surgery
Meeting the NICE threshold is not the same as being offered surgery.
The rule requiring completion of a weight management programme before assessment was dropped in 2023. What decides your chances now is set closer to home.
NICE's current guidance recommends referring an adult for a full bariatric surgery assessment at a BMI of 40 or more, or 35 to 39.9 with a significant obesity-related health condition, with an expedited assessment for anyone with a BMI of 35 or more and recently diagnosed type 2 diabetes. Thresholds are 2.5 points lower for people of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean background. Since a 2023 update, meeting this bar no longer requires having already completed a Tier 3 weight management programme or having tried and failed other treatment first, both of which the 2014 guideline it replaced required before an assessment would even be offered
NICE, Overweight and obesity management [NG246], published 14 January 2025, replacing the November 2014 guideline [CG189] Checked 2026-09-07.
NICE's own site blocks automated access the same way PHIN's does elsewhere in this register, so this is compiled from two independent secondary summaries of NG246, a BMJ practice pointer on the 2023 update and a peer reviewed factsheet in Diabetes & Primary Care, rather than read directly from NICE. Confirm the current wording with NICE or a GP before relying on it for an individual decision, because eligibility criteria are revised from time to time.
That is a real change from the guidance most people still describe to us. Under the previous NICE guideline, in force until 2023, a patient also had to show they had tried non-surgical weight management without lasting success and were already engaged with a Tier 3 specialist weight management service before a surgical assessment would even be considered, a process that commonly took a year or more on its own. NICE dropped both preconditions for referral in 2023, and the change carried through into the guideline in force today. On paper, meeting the BMI and comorbidity threshold is now enough to be offered assessment.
13 of 38
Integrated Care Systems in England that fund bariatric surgery at all, out of 41 of the country's 42 systems that responded to a 2025 freedom of information exercise, were found to apply eligibility criteria stricter than NICE recommends, among them BMI floors as high as 50 or 60, a demand for five years of documented obesity, or proof of weight already lost before a referral is accepted. A large area of England centred on the east of the country had no bariatric surgical unit at all
Elhariry, Iyer et al., Clinical Obesity, 19 January 2025 Checked 2026-09-07.
Based on how each Integrated Care System described its own policy in response to a freedom of information request, not an independent audit of every rejection. Peer reviewed, with the University of Birmingham authors' full criteria list published alongside the paper.
0 to about 1 in 100
of people estimated to be clinically eligible for referral into a specialist weight management service, the modern name for what used to be called Tier 3, were referred into one, in the regions a 2025 study could assess. Five of England’s 42 Integrated Care Boards had no such service running at all
Finer et al., Clinical Obesity, December 2025, preprint posted on medRxiv 20 December 2024 Checked 2026-09-07.
Covers the 2022 to 2023 financial year, drawn from freedom of information responses from all 42 Integrated Care Boards, with regional eligibility modelled from national survey data rather than counted patient by patient. Cited to show the referral bottleneck is real and large, not to state an exact rate for any one area.
That scale of gap is not new.
7.78 percent
of English adults, an estimated 3.6 million people, met the bariatric surgery eligibility threshold in 2014 under the same style of BMI and comorbidity criteria NICE still uses, while just over 6,000 bariatric operations were carried out across the UK that year, a rate under one in five hundred of those eligible
Desogus, Menon, Singhal and Oyebode, Obesity Surgery, 25 May 2019, using Health Survey for England data Checked 2026-09-07.
The eligible-population figure is from 2014 survey data and the operation count is UK wide rather than England only, so the two numbers are the same order of magnitude rather than a perfect pair. Obesity prevalence has risen since 2014, so this likely understates today's gap rather than overstating it. We have not found a more recent equivalent estimate to replace it.
If you have been told you do not qualify
Ask your GP or surgical team, in writing, which local policy was applied and whether it matches NICE’s published threshold. A decline under a stricter local rule is a different situation from a decline on clinical grounds, and it is worth knowing which one you are dealing with before you look further afield.
Whether you meet the national threshold or are stuck behind a stricter local one, our honest view on this specialty does not change: read what weight loss surgery abroad asks of you for years afterwards before you compare a single price. Weight loss and metabolic surgery in India
Organ transplant
The NHS's own transplant authority names a gap that a private hospital in Britain cannot close either.
2,526 people from ethnic minority backgrounds waiting (31 March 2025)
NHS Blood and Transplant, the UK’s own transplant authority, reports that ethnic-minority patients make up 35 percent of the kidney transplant waiting list but only 7 percent of deceased kidney donors, that Black patients wait up to six months longer on average than white patients for a transplant, and that 80 percent of transplants into ethnic-minority patients come from white donors, with a consent rate for donation of 35 percent among Black, Asian and minority-ethnic donor families against 67 percent among white families
NHS Blood and Transplant, Annual Report on Ethnicity Differences in Organ Donation and Transplantation, FY2024/25, published 27 November 2025 Checked 2026-09-15.
This is a matched-donor-supply gap specific to ethnicity, separate from this page’s existing general waiting-list figures, and it does not resolve by paying privately, since deceased-donor allocation in the UK is not for sale at any price.
None of this is about money. A private hospital down the road cannot buy a deceased-donor kidney any more than the NHS can, because it is not for sale at any price in either system. What decides it is a matched donor, and the supply of matched donors is where the real gap sits.
What changes this, and what does not
A living donor is a different question entirely, in Britain and in India alike. What India’s own donor law requires is worth reading before assuming a faster deceased-donor list exists anywhere.
Fertility treatment
Meeting NICE's own recommendation and getting it funded are two different things.
27 percent of UK IVF cycles NHS-funded (2023)
The UK’s fertility regulator reports that only 27 percent of IVF cycles across the UK were NHS-funded in 2023, against NICE’s own draft guidance recommending three full cycles for women under 40, and that female same-sex couples and single patients were substantially less likely than opposite-sex couples to receive NHS funding for their first cycle: roughly 16 to 18 percent funded against 52 percent for opposite-sex couples, with funding levels varying sharply by nation and region
The regulator’s own figures also report that Asian and Black patients have had lower IVF birth rates than White and mixed-ethnicity patients in recent years; this is a family-type and ethnicity-specific access and outcome gap, not a blanket cost complaint, and is separate from the funding-cycle-count claim tracked by independent charity trackers, which was not independently re-verified here to the same primary-source standard.
Where you live in the UK, your relationship status and, on the regulator’s own figures, your ethnicity all affect whether that funding reaches you. This is not a blanket claim that IVF is expensive. It is a specific, government- confirmed access gap that a straightforward cost comparison would miss entirely. India’s Assisted Reproductive Technology (Regulation) Act 2021 requires donor gametes for IVF or ICSI to be sourced only from a bank registered as an independent entity, bars that bank from supplying one donor’s sperm or oocyte to more than one commissioning couple, and requires the commissioning couple or woman to insure the oocyte donor for twelve months.
Assisted Reproductive Technology (Regulation) Act, 2021 (Act No. 42 of 2021), sections 21(b), 22(1)(b), 27(1), 27(3) and 27(4) Checked 2026-09-08.
Read from the Act as gazetted 18 December 2021. The detailed procedural mechanics sit in the subordinate ART Rules 2022, which we were not able to render as extractable text from the government’s own PDF, so treat these Act-level provisions as settled and confirm any Rules-level procedural detail directly with a registered ART bank.
Before cost enters the conversation
India runs its own eligibility rules for donor-gamete IVF, set out in a different Act entirely from anything your ICB decided to fund. Check your eligibility and your real odds before comparing a single price.
Questions
What British patients ask us.
Will the NHS treat me if something goes wrong when I get back?
Yes. You remain entitled to NHS care, and a complication arising from surgery abroad is treated like any other clinical need. What we do is make that easier on the people treating you, by sending you home with a discharge summary, imaging and an operation note in a form your GP and local hospital can act on straight away.
We put that handover in place before you fly rather than after you land, because a returning patient with no paperwork is the situation everyone wants to avoid.
Will the NHS pay for treatment in India?
NHS guidance for England says the European Health Insurance Card and the UK Global Health Insurance Card do not cover going abroad for planned medical treatments, that neither the S2 route nor the EU directive route applies to treatment outside Europe, and that for treatment in a non-European country you should speak to your local integrated care board. That is guidance for England, and Scotland, Wales and Northern Ireland run their own systems, which this page does not cover. So we cannot tell you that the NHS will fund treatment in India, and you should not book anything on the assumption that it will. If you do ask, ask in writing and keep the answer before you pay anything. What official bodies say about insurance and health plans for treatment abroad sets out the wider picture.
NHS.uk, Going abroad for medical treatment Checked 2026-09-25.
The page does not say that the NHS will pay for treatment outside Europe, only where to ask.
Is it actually cheaper than going private here?
For a complex or revision procedure, frequently yes, and the gap can be substantial. For a routine one, often not, once flights, a companion, accommodation, time away from work and the possibility of a longer stay are counted. We model your specific case against a real UK quote before you decide, and sometimes the honest answer is that Britain wins.
Can I use my private medical insurance?
Usually not for planned treatment abroad, as most UK policies are written around approved domestic providers. Check your own policy wording before assuming either way, and if you do have cover it changes the arithmetic considerably in Britain’s favour.
How long would I need to be away?
It depends on the procedure and on how your recovery goes, and any company giving you a confident figure before seeing your records is guessing. What we can do is give you a realistic range for your specific operation, and plan for the longer end rather than the shorter one.
What if I only want a second opinion, not treatment?
That is a complete service on its own and a large share of what we do. You get an independent written opinion you can take to your own consultant, and there is no expectation that anything follows it. What that includes.
If I meet the NICE weight loss surgery threshold, will I definitely be referred?
Not automatically. NICE sets the national minimum, but each Integrated Care Board can and does add its own local rules on top, and roughly a third of those funding bariatric surgery apply criteria stricter than NICE recommends. If you have been declined despite meeting the published BMI threshold, ask in writing which local policy was applied. That is the detail worth challenging.
Do I still need to complete a weight management programme before I can be considered for bariatric surgery?
You no longer have to finish one before you are even assessed. NICE removed that requirement in 2023. You will usually still go through your local specialist weight management service as part of the surgical pathway itself, and access to that service, commissioned unevenly across England, is where much of today’s delay sits.
Does the lower BMI threshold for South Asian background apply to British citizens, not just recent arrivals?
Yes. NICE’s ethnicity-adjusted thresholds are based on ancestry and the metabolic risk that comes with it, not on nationality or birthplace, so they apply to a British citizen of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean background the same way they apply to a recent migrant. Raise it directly with your GP if you are not sure it has been applied to your case.
Find out whether the flight is worth it for your case.
Thirty minutes, free, and no medical records needed to start. If a private hospital in Britain is the better answer for you, that is what you will hear.